<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94138">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01962155</url>
  </required_header>
  <id_info>
    <org_study_id>2013ZX10002005</org_study_id>
    <nct_id>NCT01962155</nct_id>
  </id_info>
  <brief_title>Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters</brief_title>
  <acronym>HBV</acronym>
  <official_title>Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our prospective study is to construct and validate a non-invasive model
      consisting biochemical markers, FibroScan, and radiological parameters for evaluating liver
      fibrosis caused by hepatitis B virus in mainland China.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>determine whether a non-invasive test or a combination of non invasive tests may be used to accurately evaluate liver fibrosis in patients with chronic hepatitis B</measure>
    <time_frame>singular evaluation at the time of liver biopsy</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Hepatitis B</condition>
  <condition>Liver Fibrosis</condition>
  <arm_group>
    <arm_group_label>chronic infected with hepatitis B virus</arm_group_label>
    <description>patients infected with hepatitis B virus for at least 6 months and agreed with liver biopsy</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      liver biopsy samples and blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients infected with hepatitis B virus for at least 6 months
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. HBsAg positive for at least 6 months

          2. agree to have liver biopsy

          3. Male or female aged 18 to 65 years old

        Exclusion Criteria:

          1. Patients with alcoholic liver disease, autoimmune liver disease, heretic liver
             disease, drug induced liver disease,nonalcoholic liver disease or other chronic liver
             disease

          2. platelet count &lt; 80000/L

          3. prothrombin activity â‰¤ 60%

          4. patients with any disease or condition which the investigator or treating physician
             feels would interfere with the trial or the safety of the subject
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guiqiang Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guiqiang Wang</last_name>
    <phone>13911405123</phone>
    <email>john131212@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hong Zhao</last_name>
    <phone>13810765943</phone>
    <email>minmin2001@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiabin Li</last_name>
      <phone>13855148570</phone>
      <email>lijiabin948@163.com</email>
    </contact>
    <investigator>
      <last_name>Jiabin Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Bei Jing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guiqiang Wang, MD</last_name>
      <phone>86-13911405123</phone>
      <email>john131212@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hong Zhao, MD</last_name>
      <phone>86-13810765942</phone>
      <email>minmin2001@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Guiqiang Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>302 Military Hospital of China</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liming Chen, MD</last_name>
      <phone>86-13021293636</phone>
      <email>hm160@sina.cn</email>
    </contact>
    <investigator>
      <last_name>LiMing Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Ditan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>10000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Cheng, MD</last_name>
      <phone>86-10-64281540</phone>
      <email>jun.cheng@bjditan.org</email>
    </contact>
    <investigator>
      <last_name>Jun Cheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest Hospital, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuqing Zhang</last_name>
      <phone>86-13527485619</phone>
      <email>xuqing651005@tom.com</email>
    </contact>
    <investigator>
      <last_name>Xuqing Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dazhi Zhang, MD</last_name>
      <phone>86-13452382818</phone>
      <email>zhangdzh@etang.com</email>
    </contact>
    <investigator>
      <last_name>Dazhi Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangzhou Eighth People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaobing Hu</last_name>
      <phone>13711307178</phone>
      <email>Dr.HXB@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaobing Hu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shibin Xie, MD</last_name>
      <phone>86-13922244948</phone>
      <email>xieshibin1964@163.com</email>
    </contact>
    <investigator>
      <last_name>Shibin Xie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third people's Hospital of Shenzhen</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingxia Liu</last_name>
      <phone>13603096453</phone>
      <email>yingxialiu@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Yingxia Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Guangxi Zhuang Autonomous Region</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo Zhang</last_name>
      <phone>13978839646</phone>
      <email>zhangguogx@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Guo Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third People's Hospital of Qinhuangdao</name>
      <address>
        <city>Qinhuangdao</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xun Peng</last_name>
      <phone>18603361960</phone>
      <email>pengxun1960@163.com</email>
    </contact>
    <investigator>
      <last_name>Xun Peng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Xinxiang Medical University</name>
      <address>
        <city>Xinxiang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weifeng Zhao</last_name>
      <phone>13837313280</phone>
      <email>zwf7577@126.com</email>
    </contact>
    <investigator>
      <last_name>Weifeng Zhao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Shang</last_name>
      <phone>13938401888</phone>
      <email>shangjia666@126.com</email>
    </contact>
    <investigator>
      <last_name>Jia Shang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zuojiong Gong</last_name>
      <phone>13971687857</phone>
      <email>zjgong@163.com</email>
    </contact>
    <investigator>
      <last_name>Zuojiong Gong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wangxian Tang</last_name>
      <phone>15907118789</phone>
      <email>tangwx@tjh.tjmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Wangxian Tang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guozhong Gong</last_name>
      <phone>13873104819</phone>
      <email>guozhonggong@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Guozhong Gong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Li</last_name>
      <phone>13905175333</phone>
      <email>prof.lijun@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jun Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Nanjing</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Zhao</last_name>
      <phone>13951901772</phone>
    </contact>
    <investigator>
      <last_name>Wei Zhao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>81 Military Hospital of China</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maorong Wang</last_name>
      <phone>13401935666</phone>
      <email>maorongwang@126.com</email>
    </contact>
    <investigator>
      <last_name>Maorong Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dalian the Sixth People's Hospital</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanli Sun</last_name>
      <phone>13898657676</phone>
    </contact>
    <investigator>
      <last_name>Wanli Sun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Sixth People's Hospital of Shenyang</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mingxiang Zhang</last_name>
      <phone>13386868855</phone>
      <email>zmx6511@126.com</email>
    </contact>
    <investigator>
      <last_name>Mingxiang Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yantai City Hospital for Infectious Diseases</name>
      <address>
        <city>Yantai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiqiang Zhou</last_name>
      <phone>13306387366</phone>
      <email>zhiqiangzou@126.com</email>
    </contact>
    <investigator>
      <last_name>Zhiqiang Zhou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shan Xi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Longfeng Zhao</last_name>
      <phone>13934519086</phone>
    </contact>
    <investigator>
      <last_name>Longfeng Zhao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhejiang First Hospital</name>
      <address>
        <city>Hang Zhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weifeng Liang, MD</last_name>
      <phone>86-13957163061</phone>
      <email>dr.liangwf@163.com</email>
    </contact>
    <investigator>
      <last_name>Weifeng Liang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anlin Ma</last_name>
      <phone>13910253710</phone>
      <email>maanlinjc@163.com</email>
    </contact>
    <investigator>
      <last_name>Anlin Ma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 305 Hospital of People's Liberation Army</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhijin Wang</last_name>
      <phone>15301018578</phone>
    </contact>
    <investigator>
      <last_name>Zhijin Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Youan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Lv</last_name>
      <phone>13661381489</phone>
      <email>lujun98@ccmu.edu.com</email>
    </contact>
    <investigator>
      <last_name>Jun Lv</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liang Bai</last_name>
      <phone>86-18980602254</phone>
      <email>pangbailang@163.com</email>
    </contact>
    <investigator>
      <last_name>Liang Bai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Public Health Clinical Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanqing Zhang</last_name>
      <phone>18916039958</phone>
      <email>doctorzzqsphc@163.com</email>
    </contact>
    <investigator>
      <last_name>Zhanqing Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Ruijin Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qing Xie</last_name>
      <phone>13651804273</phone>
      <email>xieqingrjh@163.com</email>
    </contact>
    <investigator>
      <last_name>Qing Xie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>October 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Guiqiang Wang</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Fibrosis</keyword>
  <keyword>Liver Cirrhosis</keyword>
  <keyword>non-invasive</keyword>
  <keyword>biopsy</keyword>
  <keyword>hepatitis B virus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
